Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biotron ( (AU:BIT) ) has issued an announcement.
Biotron Limited has announced the quotation of 33,333,333 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective December 10, 2025. This move is part of a previously announced transaction and is expected to enhance Biotron’s market presence and provide additional capital to support its ongoing research and development efforts.
More about Biotron
Biotron Limited operates in the biotechnology industry, focusing on the development of novel antiviral therapies. The company is engaged in creating innovative solutions to address significant unmet needs in the treatment of viral infections.
YTD Price Performance: -38.89%
Technical Sentiment Signal: Sell
Current Market Cap: A$4.98M
For an in-depth examination of BIT stock, go to TipRanks’ Overview page.